This report provides an in-depth review of the seven1 World Health Organization's (WHO) Emergency Use Listing (EUL) authorized vaccines: BNT162b2/ COMIRNATY (Pfizer-BioNTech, USA), Spikevax/ Moderna COVID-19 Vaccine/ mRNA-1273 (Moderna, USA), Vaxzevria/ ChAdOx1 nCoV-19/ AZD1222/ Covishield (AstraZeneca/Oxford, UK, India), Janssen Covid-19 vaccine/ Ad26CoV2.S/ Johnson & Johnson (Janssen, USA), Sinopharm/ BBIBP-CorV (China), Sinovac/ CoronaVac (China), and COVAXIN/ BBV152 (Bharat Biotech, India)]. The current report summarises the latest data on COVID-19 vaccine-related literature as of 13 December 2021, and presents the information in the form of a synoptic table. This report covers vaccine effectiveness, protection against variants, transmissibility, breakthrough infections, booster doses, COVID-19 vaccines for children, and further important information for each vaccine. The latest changes and additions to the synoptic table are highlighted in yellow.